Removal of small exogenous molecules from biological fluids

Liquid purification or separation – Processes – Liquid/liquid solvent or colloidal extraction or diffusing...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

210656, 530413, 530417, B01D 1500, B01D 1508

Patent

active

054862930

ABSTRACT:
Novel sorbents and methods for removing small hydrophobic and amphophilic molecules from biological fluids were disclosed. The methods and materials were particularly useful for removing viral inactivating agents from blood and blood fractions. The novel sorbents comprise a porous mineral oxide matrix having its interior porous volume substantially filled with a crosslinked hydrophobic polymer network.

REFERENCES:
patent: 4481189 (1984-11-01), Prince
patent: 4540573 (1985-09-01), Neurath et al.
patent: 4615886 (1986-10-01), Purcell et al.
patent: 4720385 (1988-01-01), Lembach
patent: 4764369 (1988-08-01), Neurath et al.
patent: 4841023 (1989-06-01), Horowitz
patent: 4857514 (1989-08-01), Lippa et al.
patent: 4939176 (1990-07-01), Seng et al.
patent: 5053135 (1991-10-01), Boschetti et al.
patent: 5151499 (1992-09-01), Kameyama et al.
patent: 5186945 (1993-02-01), Shanbrom
patent: 5204324 (1993-04-01), Shanbrom
patent: 5268097 (1993-12-01), Girot et al.
Prince et al. "Inactivation of Hepatitis B and Hutchinson Strain Non-A, Non-B Hepatitis Viruses . . . " Vox Sang 46, 36-43 (1984).
Prince et al. "Quantitative Assays for Evaluation of HTLV-III Inactivation . . . " Cancer Research 45, 4592s-4594s (1985).
Prince et al. "Sterilisation of Hepatitis and HTLV-III Viruses by Exposure to . . . " The Lancet, Mar. 29, 1986, pp. 706-709.
Horowitz et al. "Inactivation of viruses in labile blood derivatives" Transfusion 25, 516-522 (1985).
Edwards et al. "Tri (n-Butyl) Phosphate/Detergent Treatment of Licensed Therapeutic . . . " Vox Sang 52, 53-59 (1987).
Horowitz et al. "Inactivation of Lipid-Enveloped Viruses in Labile Blood Derivatives . . . " Vox Sang 54, 14-20 (1988).
Horowitz et al. "Solvent/Detergent-Treated Plasma: A Virus-Inactivated Substitute . . . " Blood 79, 3, 826-831 (1992).
DiPaolantonio, et al. "Low Risk of Transmission of the Human Immunodeficiency . . . " J. Med. Virology 36, 71-74 (1992).
Piquet et al. "Virus Inactivation of Fresh Frozen Plasma by a Solvent Detergent Procedure: . . . " Vox Sang 63, 251-256 (1992).
Michalski et al. "Large-Scale Production and Properties of a Solvent-Detergent-Treated . . . " Vox Sang 55, 202-210 (1988).
Strancar et al. "Extraction of Triton X-100 and its determination in virus-inactivated . . . " J. Chrom. A. 658, 475-481 (1994).
L. Guerrier et al., Journal of Chromatography B: Biomedical Applications, 664, pp. 119-125 (1995).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Removal of small exogenous molecules from biological fluids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Removal of small exogenous molecules from biological fluids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Removal of small exogenous molecules from biological fluids will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1503170

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.